← Back to Search

Probiotic

Probiotic Yogurt for Antibiotic-Associated Diarrhea (PLAY ON Trial)

Phase 2
Waitlist Available
Led By Daniel Merenstein, MD
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

PLAY ON Trial Summary

This trial is testing whether a specific probiotic can help prevent antibiotic-associated diarrhea in children.

Who is the study for?
This trial is for healthy children aged 3-12 on antibiotics for respiratory infections, who have access to a fridge and whose caregivers can communicate in English or Spanish. It's not suitable for kids with chronic conditions like diabetes or asthma, those with heart disease, gastrointestinal issues, allergies to certain antibiotics or milk protein, lactose intolerance beliefs, prematurity, congenital anomalies, or active diarrhea.Check my eligibility
What is being tested?
The study tests if high-dose BB-12 probiotic yogurt can prevent antibiotic-associated diarrhea in children taking antibiotics compared to regular yogurt. It also examines the safety of this probiotic-enriched yogurt and its effects on the diversity of gut bacteria over time.See study design
What are the potential side effects?
While specific side effects are not listed here, generally probiotics like BB-12 are considered safe but may cause digestive discomfort such as gas or bloating initially. Any unexpected reactions related to the consumption of the supplemented yogurt will be closely monitored.

PLAY ON Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diarrhea
Secondary outcome measures
Pediatric quality-of-life score
Symptoms of loose stools, constipation, fever, flatulence, lack of appetite, pain, rash, vomiting, cough, earache, nasal congestion, runny nose, sore throat.

PLAY ON Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BB-12Experimental Treatment1 Intervention
Bifidobacterium animalis subsp. lactis BB-12 (BB-12)-supplemented yogurt
Group II: ControlPlacebo Group1 Intervention
Yogurt without Bifidobacterium animalis subsp. lactis BB-12
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bifidobacterium animalis subsp. lactis BB-12
2017
Completed Phase 2
~260

Find a Location

Who is running the clinical trial?

Penn State UniversityOTHER
355 Previous Clinical Trials
125,502 Total Patients Enrolled
1 Trials studying Antibiotic-associated Diarrhea
138 Patients Enrolled for Antibiotic-associated Diarrhea
University of Maryland, BaltimoreOTHER
687 Previous Clinical Trials
374,391 Total Patients Enrolled
2 Trials studying Antibiotic-associated Diarrhea
204 Patients Enrolled for Antibiotic-associated Diarrhea
Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,247 Total Patients Enrolled
2 Trials studying Antibiotic-associated Diarrhea
204 Patients Enrolled for Antibiotic-associated Diarrhea

Media Library

BB-12 Supplemented Strawberry Yogurt (Probiotic) Clinical Trial Eligibility Overview. Trial Name: NCT03181516 — Phase 2
Antibiotic-associated Diarrhea Research Study Groups: BB-12, Control
Antibiotic-associated Diarrhea Clinical Trial 2023: BB-12 Supplemented Strawberry Yogurt Highlights & Side Effects. Trial Name: NCT03181516 — Phase 2
BB-12 Supplemented Strawberry Yogurt (Probiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03181516 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA officially sanctioned Bifidobacterium animalis subsp. lactis BB-12?

"After careful evaluation, our team at Power rated the safety of Bifidobacterium animalis subsp. lactis BB-12 as a 2 since this is only in Phase 2 clinical trials and there is limited information currently available on its efficacy."

Answered by AI

What is the aggregate size of the cohort involved in this experiment?

"Affirmative. As evidenced by clinicaltrials.gov, this medical investigation is currently enrolling participants; the trial was posted on September 30th 2017 and has since been updated on June 27th 2022. This study seeks to enlist 300 people from a single location."

Answered by AI

Does this medical experiment currently have openings for participants?

"According to the data hosted on clinicaltrials.gov, this medical trial is actively seeking participants and was initially posted on September 30th 2017 with its most recent edit being June 27th 2022."

Answered by AI

Is the enrollment criteria for this investigation limited to individuals over 40 years of age?

"This trial is specifically designed for children between the ages of 3 and 12. Patients younger than 18 have 28 other clinical trials available to them, while seniors over 65 can access 46 different studies."

Answered by AI

Am I eligible to be a participant in this clinical trial?

"Those interested in this clinical trial must be aged between 3 and 12, while also presenting with diarrhea. The study is seeking to recruit a total of 300 individuals."

Answered by AI
~34 spots leftby Apr 2025